Maimon Yossi - Net Worth and Insider Trading

Maimon Yossi Net Worth

The estimated net worth of Maimon Yossi is at least $21,450 dollars as of 2024-05-12. Maimon Yossi is the Vice President & CFO of Protalix BioTherapeutics Inc and owns about 19,500 shares of Protalix BioTherapeutics Inc (PLX) stock worth over $21,450. Details can be seen in Maimon Yossi's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Maimon Yossi has not made any transactions after 2015-12-14 and currently still holds the listed stock(s).

Transaction Summary of Maimon Yossi

To

Maimon Yossi Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Maimon Yossi owns 2 companies in total, including Ayala Pharmaceuticals Inc (ADXS) , and Protalix BioTherapeutics Inc (PLX) .

Click here to see the complete history of Maimon Yossi’s form 4 insider trades.

Insider Ownership Summary of Maimon Yossi

Ticker Comapny Transaction Date Type of Owner
ADXS Ayala Pharmaceuticals Inc 2020-05-07 CFO
PLX Protalix BioTherapeutics Inc 2015-12-14 VP & Chief Financial Officer

Maimon Yossi Latest Holdings Summary

Maimon Yossi currently owns a total of 1 stock. Maimon Yossi owns 19,500 shares of Protalix BioTherapeutics Inc (PLX) as of December 14, 2015, with a value of $21,450.

Latest Holdings of Maimon Yossi

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
PLX Protalix BioTherapeutics Inc 2015-12-14 19,500 1.10 21,450

Holding Weightings of Maimon Yossi


Maimon Yossi Form 4 Trading Tracker

According to the SEC Form 4 filings, Maimon Yossi has made a total of 0 transactions in Protalix BioTherapeutics Inc (PLX) over the past 5 years. The most-recent trade in Protalix BioTherapeutics Inc is the acquisition of 1,000 shares on December 14, 2015, which cost Maimon Yossi around $7,800.

Insider Trading History of Maimon Yossi

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Maimon Yossi Trading Performance

GuruFocus tracks the stock performance after each of Maimon Yossi's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Maimon Yossi is 19.23%. GuruFocus also compares Maimon Yossi's trading performance to market benchmark return within the same time period. The performance of stocks bought by Maimon Yossi within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Maimon Yossi's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Maimon Yossi

Average Return

Average return per transaction

Outperforming Transactions

0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 8.97
Relative Return to S&P 500(%) 13.92

Maimon Yossi Ownership Network

Ownership Network List of Maimon Yossi

No Data

Ownership Network Relation of Maimon Yossi


Maimon Yossi Owned Company Details

What does Ayala Pharmaceuticals Inc do?

Who are the key executives at Ayala Pharmaceuticals Inc?

Maimon Yossi is the CFO of Ayala Pharmaceuticals Inc. Other key executives at Ayala Pharmaceuticals Inc include other: shareholder of 10% holder Yair Chaim Schindel , director & CEO Roni Mamluk , and Chief Medical Officer Gary B. Gordon .

Ayala Pharmaceuticals Inc (ADXS) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Ayala Pharmaceuticals Inc (ADXS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Ayala Pharmaceuticals Inc (ADXS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Ayala Pharmaceuticals Inc (ADXS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Ayala Pharmaceuticals Inc Insider Transactions

No Available Data

Maimon Yossi Mailing Address

Above is the net worth, insider trading, and ownership report for Maimon Yossi. You might contact Maimon Yossi via mailing address: C/o Protalix Biotherapeutics, Inc., 2 Snunit St, Science Park, Pob 455, Carmiel L3 20100.

Discussions on Maimon Yossi

No discussions yet.